Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
24.75
+0.01 (0.04%)
May 19, 2026, 4:00 PM EDT - Market closed
Avanos Medical Revenue
Avanos Medical had revenue of $182.20M in the quarter ending March 31, 2026, with 8.78% growth. This brings the company's revenue in the last twelve months to $715.90M, up 3.87% year-over-year. In the year 2025, Avanos Medical had annual revenue of $701.20M with 1.95% growth.
Revenue (ttm)
$715.90M
Revenue Growth
+3.87%
P/S Ratio
1.62
Revenue / Employee
$313,030
Employees
2,287
Market Cap
1.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 701.20M | 13.40M | 1.95% |
| Dec 31, 2024 | 687.80M | 14.50M | 2.15% |
| Dec 31, 2023 | 673.30M | -10.80M | -1.58% |
| Dec 31, 2022 | 684.10M | 97.10M | 16.54% |
| Dec 31, 2021 | 587.00M | -127.80M | -17.88% |
| Dec 31, 2020 | 714.80M | 17.20M | 2.47% |
| Dec 31, 2019 | 697.60M | 45.30M | 6.94% |
| Dec 31, 2018 | 652.30M | 40.70M | 6.65% |
| Dec 31, 2017 | 611.60M | 45.40M | 8.02% |
| Dec 31, 2016 | 566.20M | 57.20M | 11.24% |
| Dec 31, 2015 | 509.00M | -1.16B | -69.56% |
| Dec 31, 2014 | 1.67B | -5.40M | -0.32% |
| Dec 31, 2013 | 1.68B | -6.50M | -0.39% |
| Dec 31, 2012 | 1.68B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.29B |
| Enovis | 2.28B |
| Integra LifeSciences Holdings | 1.64B |
| CONMED | 1.37B |
| Inspire Medical Systems | 915.25M |
| Alphatec Holdings | 787.08M |
| Bioventus | 576.30M |
| Artivion | 458.69M |
AVNS News
- 14 days ago - Avanos Medical Quarterly report: Q1 2026 - Filings
- 14 days ago - Avanos Medical Earnings release: Q1 2026 - Filings
- 14 days ago - Avanos Medical Proxy statement: Proxy filing - Filings
- 14 days ago - Avanos Medical, Inc. Announces First Quarter 2026 Results - PRNewsWire
- 26 days ago - Avanos Medical Proxy statement: Proxy filing - Filings
- 5 weeks ago - This Healthcare Stock Is Rising 69%. It's Getting Bought Out for a Big Premium. - Barrons
- 5 weeks ago - Avanos Medical Proxy statement: Proxy filing - Filings
- 5 weeks ago - Avanos Medical Proxy statement: Proxy filing - Filings